Research Article

Antifungal Susceptibility Patterns of Candida Species Recovered from Endotracheal Tube in an Intensive Care Unit

Table 2

MIC interpretation of five antifungal drugs against Candida spp. recovered from endotracheal tube.

Antifungal agentsC. albicans

(%)
C. glabrata

(%)
C. parapsilosis

(%)
C. tropicalis

(%)
C. krusei

(%)

Amphotericin BS28 (82.3)20 (83.3)16 (100)10 (83.3)7 (77.7)
R6 (17.6)4 (16.6)2 (16.7)2 (22.2)

ItraconazoleS20 (58.8)12 (50)6 (37.5)4 (33.3)3 (33.3)
DD2 (5.8)6 (25)10 (62.5)5 (55.5)
R12 (35.2)6 (25)8 (66.6)1 (11.1)

Voriconazole S27 (79.4)11 (45.8)12 (75)4 (33.3)6 (66.6)
DD2 (5.8)5 (20.8)4 (25)3 (25)2 (22.2)
R5 (14.7)8 (33.3)5 (41.6)1 (11.1)

Fluconazole S22 (64.7)3 (12.5)14 (87.5)3 (25)5 (55.5)
DD3 (8.8)2 (8.3)2 (12.5)4 (33.3)2 (22.2)
R9 (26.4)19 (79.1)5 (41.6)2 (22.2)

Caspofungin S34 (100)24 (100)16 (100)12 (100)9 (100)
R

S: susceptible; R: resistance; DD: dose-dependent.